VAERS reports by lot

Moderna COVID-19 lot 01A21A: VAERS reports

23 VAERS reports list lot 01A21A as a Moderna COVID-19 vaccine, received between 2021-03-01 and 2022-08-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
30%
Marked serious
4
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1719%
Neurological1618%
Gastrointestinal1315%
Injection-site / Local reaction1112%
Respiratory1011%
Cardiac / Cardiovascular89%
Dermatological (non-injection-site)56%
Allergic / Anaphylactic33%
Musculoskeletal33%
Psychiatric / Neuropsychiatric22%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida3
Minnesota2
Tennessee2
New York2
Arizona1
Indiana1
Washington1
Michigan1
Wisconsin1
Maine1
California1
Kentucky1

Reports by month received

2021-035
2021-042
2021-051
2021-071
2021-085
2021-103
2021-111
2022-021
2022-032
2022-041
2022-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.